Target Price | $19.00 |
Price | $3.66 |
Potential |
419.13%
register free of charge
|
Number of Estimates | 1 |
1 Analyst has issued a Marker Therapeutics, Inc. price target 2025.
The average Marker Therapeutics, Inc. target price is $19.00.
This is
419.13%
register free of charge
|
|
A rating was issued by 1 analysts: 1 Analysts recommend Marker Therapeutics, Inc. to buy, 0 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Marker Therapeutics, Inc. stock has an average upside potential 2025 of
419.13%
register free of charge
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Revenue Million $ | 3.31 | 4.41 |
39.82% | 33.32% | |
Net Margin | -518.94% | -288.40% |
10.42% | 44.43% |
1 Analyst has issued a sales forecast Marker Therapeutics, Inc. 2024 . The average Marker Therapeutics, Inc. sales estimate is
This results in the following potential growth metrics:
2023 | $3.3m | 39.82% |
---|---|---|
2024 |
$4.4m
33.32%
Unlock
|
1 Analyst has issued a net profit forecast Marker Therapeutics, Inc. 2024 . The average Marker Therapeutics, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
2023 | -518.94% | 10.42% |
---|---|---|
2024 |
-288.40%
44.43%
Unlock
|
Dec '23 |
2024 Estimates |
|
---|---|---|
Earnings Per Share $ | -1.93 | -1.43 |
46.09% | 25.91% | |
P/E | negative | |
EV/Sales | 5.63 |
1 Analysts have issued a Marker Therapeutics, Inc. forecast for earnings per share. The average Marker Therapeutics, Inc. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2024, the Marker Therapeutics, Inc. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Current | 6.66 | 1,565.00% |
---|---|---|
2024 |
5.63
15.41%
Unlock
|
Current | 8.76 | 358.84% |
---|---|---|
2024 |
7.40
15.48%
Unlock
|
Marker Therapeutics, Inc....
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.